ACM Research (ACMR) EBITDA (2016 - 2026)

ACM Research has disclosed EBITDA across 11 years of filings, most recently posting $54.0 million for Q1 2026.

• In Q1 2026, EBITDA rose 101.89% year-over-year to $54.0 million; the TTM figure through Mar 2026 stood at $184.9 million (up 33.89% YoY), while the FY2025 annual figure was $157.6 million, up 35.91% from the prior year.
• EBITDA rose to $54.0 million in Q1 2026, from $32.0 million in the prior quarter.
• Over the last five years, EBITDA for ACMR reached as high as $58.7 million in Q3 2025 and fell as low as -$23.6 million in Q2 2022.
• The 5-year median for EBITDA is $28.7 million (2023), against an average of $23.3 million.
• Annual changes were most pronounced in 2022 — EBITDA tumbled 376.72% — and 2024, when it jumped 1456.07%.
• A 5-year view of EBITDA shows it stood at $35.4 million in 2022, then retreated by 18.95% to $28.7 million in 2023, then increased by 21.54% to $34.9 million in 2024, then declined by 8.3% to $32.0 million in 2025, then jumped by 68.89% to $54.0 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $54.0 million, $32.0 million, and $58.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.